<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="99259">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01812447</url>
  </required_header>
  <id_info>
    <org_study_id>CPR-03434</org_study_id>
    <nct_id>NCT01812447</nct_id>
  </id_info>
  <brief_title>Evaluation of the Spiration® Valve System for Emphysema to Improve Lung Function</brief_title>
  <acronym>EMPROVE</acronym>
  <official_title>A Prospective, Randomized, Controlled Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Spiration® Valve System for the Single Lobe Treatment of Severe Emphysema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spiration, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spiration, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      EMPROVE is a multicenter, prospective, randomized, controlled study designed to evaluate the
      safety and long-term effectiveness of the Spiration Valve System in patients with emphysema.

      Patients appropriate for the EMPROVE study are those who are currently on medical treatment
      but still symptomatic.

      EMPROVE also accepts α-1 antitrypsin deficiency patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Spiration Valve is a small, one-way valve that is used to block air from entering
      diseased portions of the lung. This helps to reduce the volume in diseased lung due to
      hyperinflation. Volume reduction of diseased lung has been shown to improve lung function
      and other quality of life measures for people living with emphysema.

      The Spiration Valve is placed in the diseased section of the lungs using a tool called a
      bronchoscope. A bronchoscope is a small tube that has a camera on the end. The bronchoscope
      enters the lungs through the mouth. The Spiration Valve is delivered and placed in the
      targeted airways via another thin tube called a catheter that travels through the
      bronchoscope.

        -  Once in place, the Spiration Valve expands and contracts with breathing, creating a
           complete seal around the airway

        -  The seal blocks air from entering the target lobe while at the same time allowing
           trapped air and fluids to escape.

        -  This causes the diseased (hyper-inflated) lung to reduce in volume or collapse

        -  Studies have shown volume reduction may allow healthier lung to function better

        -  More information and a description of the Spiration Valve System can be found on the
           EMPROVE clinical trial website, www.EmphysemaTrial.com

      Safety and outcomes of the Spiration Valve System in emphysema have been published in
      several peer-reviewed journals. The articles listed below represent a summary of existing
      literature regarding the use of the Spiration Valve System for the treatment of emphysema.
      The selected articles are being provided to help understand the body of data describing the
      use of the Spiration Valve System.

        1. Unilateral Versus Bilateral Endoscopic Lung Volume Reduction: A Comparative Case Study,
           NCT00995852

           Eberhardt R, Gompelmann D, Schuhmann M, Heussel CP, Herth FJ. Complete unilateral vs
           partial bilateral endoscopic lung volume reduction in patients with bilateral lung
           emphysema. Chest. 2012 Oct;142(4):900-908

        2. Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for
           the Treatment of Severe Emphysema (IBV®Valve), NCT00475007

           Wood DE, Nader DA, Springmeyer SC, Elstad MR, Coxson HO, Chan A, Rai NS, Mularski RA,
           Cooper CB, Wise RA, Jones PW, Mehta AC, Gonzalez X, Sterman DH; IBV Valve Trial
           Research Team. The IBV Valve trial: a multicenter, randomized, double-blind trial of
           endobronchial therapy for severe emphysema. J Bronchology Interv Pulmonol. 2014
           Oct;21(4):288-297

        3. European Multi-Center Post Market Study of the IBV Valve System, NCT00880724

      Ninane V, Geltner C, Bezzi M, Foccoli P, Gottlieb J, Welte T, Seijo L, Zulueta JJ, Munavvar
      M, Rosell A, Lopez M, Jones PW, Coxson HO, Springmeyer SC, Gonzalez X. Multicentre European
      study for the treatment of advanced emphysema with bronchial valves. Eur Respir J. 2012
      Jun;39(6):1319-1325
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary effectiveness endpoint will be the difference between the treatment and control groups in the mean change in forced expiratory volume in 1 second (FEV1)</measure>
    <time_frame>Baseline and 6 Months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Target lobe volume reduction as measured by QCT</measure>
    <time_frame>Baseline and 6 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hyperinflation as measured by the ratio of Residual Volume to Total Lung Capacity (RV/TLC)</measure>
    <time_frame>Baseline and 6 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Status as measured by St. George's Respiratory Questionnaire (SGRQ)</measure>
    <time_frame>Baseline and 6 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea as measured by Modified Medical Research Council Questionnaire (mMRC)</measure>
    <time_frame>Baseline and 6 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise capacity as measured by Six Minute Walk Test (6MWT)</measure>
    <time_frame>Baseline and 6 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FEV1 Responders, defined as those achieving at least 15% improvement from baseline</measure>
    <time_frame>Baseline and 6 Months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of thoracic SAEs</measure>
    <time_frame>Baseline and 6 months</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">270</enrollment>
  <condition>Emphysema</condition>
  <arm_group>
    <arm_group_label>Spiration Valve System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects assigned to the treatment group will undergo a bronchoscopic procedure to have valves placed in the most diseased lobe of the lung to occlude all segments of the lobe. Subjects assigned to this group will also receive medical management.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spiration Valve System, α-1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>α-1 antitrypsin deficiency subjects will undergo a bronchoscopic procedure to have valves placed in the most diseased lobe of the lung to occlude all segments of the lobe. Subjects assigned to this group will also receive medical management. There is no randomization for this group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medical Management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group for this study will receive medical management. This medical management group will be evaluated and followed in the same manner as the treatment group, but without having a bronchoscopic procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spiration Valve System</intervention_name>
    <description>Subjects assigned to the treatment group will undergo a bronchoscopic procedure to have valves placed in the most diseased lobe of the lung to occlude all segments of the lobe.</description>
    <arm_group_label>Spiration Valve System</arm_group_label>
    <arm_group_label>Spiration Valve System, α-1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medical Management</intervention_name>
    <description>Stable management is based on the ACP/ACCP/ATS/ERS Guidelines for Management of Stable COPD. Medical management will include management of COPD medications, oxygen use, and pulmonary rehabilitation.</description>
    <arm_group_label>Spiration Valve System</arm_group_label>
    <arm_group_label>Spiration Valve System, α-1</arm_group_label>
    <arm_group_label>Medical Management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject has severe and heterogeneous emphysema with severe dyspnea

          -  Subject certified to meet the criteria of ATS/ERS guidelines for management of stable
             COPD

          -  Subject must be able to demonstrate physical ability to participate in the study by
             performing a 6-minute walk distance of ≥ 140 m

          -  Subject has abstained from cigarette smoking for 4 months and is willing to abstain
             throughout the study

          -  Pulmonary Function Testing Results (PFT's) demonstrate:

               -  FEV1 ≤ 45% of predicted

               -  RV ≥ 150% of predicted

               -  TLC ≥ 100% of predicted

        Exclusion Criteria:

          -  Patient has a BMI &lt; 15 kg/m2

          -  Arterial Blood Gas Level (ABG) indicates:

               -  PCO2 &gt; 55 mm Hg

               -  PO2 &lt; 45 mm Hg on room air

          -  Subject has a diffuse emphysema pattern

          -  Subject has bronchitis with sputum production &gt; 4 Tablespoons or 60 ml per day

          -  Subject has an active asthma (&gt;15 mg of prednisone daily)

          -  Giant bulla (&gt; 1/3 volume of lung)

          -  Pulmonary hypertension

          -  Subject with prior major lung surgery or recent hospitalization for COPD exacerbation
             or respiratory infections
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sparks Regional Medical Center</name>
      <address>
        <city>Fort Smith</city>
        <state>Arkansas</state>
        <zip>72901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristi Lokey</last_name>
      <phone>479-441-4938</phone>
      <email>kristi.lokey@sparkshealth.com</email>
    </contact>
    <investigator>
      <last_name>Arturo Meade, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Riverside Medical Center</name>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <zip>92505</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erika Britton</last_name>
      <phone>951-353-5801</phone>
      <phone_ext>258</phone_ext>
    </contact>
    <investigator>
      <last_name>Greg Marrujo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>California Pacific Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna von Bakonyi</last_name>
      <phone>415-600-1107</phone>
      <email>vonbaka@CPMCRI.org</email>
    </contact>
    <investigator>
      <last_name>Benson Chen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Verna Skinner</last_name>
      <phone>904-953-2255</phone>
      <email>skinner.verna@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Jorge Mallea, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Miami VA Healthcare System</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33125</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valeria Bagley</last_name>
      <phone>305-575-7000</phone>
      <phone_ext>4816</phone_ext>
      <email>Valeria.Bagley@va.gov</email>
    </contact>
    <investigator>
      <last_name>Gregory Holt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sarasota Memorial Hospital</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Barrentine, RN</last_name>
      <phone>941-917-3614</phone>
      <email>heather-barrentine@smh.com</email>
    </contact>
    <investigator>
      <last_name>Kirk Voelker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Rauen, BSN, RN</last_name>
      <phone>813-844-7647</phone>
      <email>crauen@tgh.org</email>
    </contact>
    <investigator>
      <last_name>Mark Rumbak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liz Wilkins</last_name>
      <phone>770-745-1404</phone>
      <phone_ext>6</phone_ext>
    </contact>
    <investigator>
      <last_name>Amy Case, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60561</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cyndy Warnes, RN, BSN</last_name>
      <phone>773-834-8874</phone>
    </contact>
    <investigator>
      <last_name>Kyle Hogarth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allison (Allie) Rogowski</last_name>
      <phone>312-695-4828</phone>
      <email>allison.rogowski1@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Ravi Kalhan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Louisiana State University Hospital</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Mullins, RN</last_name>
      <phone>318-675-7298</phone>
      <email>amulli@lsuhsc.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Holladay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer McGrain</last_name>
      <phone>410-328-1473</phone>
      <email>jmcgrain@medicine.umaryland.edu</email>
    </contact>
    <investigator>
      <last_name>Ashutosh Sachdeva, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexis Agnew</last_name>
      <phone>617-632-8386</phone>
    </contact>
    <investigator>
      <last_name>Adnan Majid, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lahey Clinic</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joyce Pelletier</last_name>
      <phone>781-744-3706</phone>
    </contact>
    <investigator>
      <last_name>Carla Lamb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beaumont Botsford Hospital (DCRC)</name>
      <address>
        <city>Farmington Hills</city>
        <state>Michigan</state>
        <zip>48336</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Morten Fornaess</last_name>
      <phone>248-716-7009</phone>
      <email>morten.fornaess@dcrc.us</email>
    </contact>
    <investigator>
      <last_name>Philip Kaplan, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cooper University Hospital</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cornell NYPH</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cathy Spinelli</last_name>
      <phone>212-746-3328</phone>
      <email>caf2007@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Eugene Shostak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Kearney-Bryan</last_name>
      <phone>704-355-0244</phone>
    </contact>
    <investigator>
      <last_name>Michael Zgoda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Ingledue</last_name>
      <phone>513-558-0027</phone>
      <email>ingledra@ucmail.uc.edu</email>
    </contact>
    <investigator>
      <last_name>Sadia Benzaquen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Northwest Medical Center</name>
      <address>
        <city>Clackamas</city>
        <state>Oregon</state>
        <zip>97015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Carlson</last_name>
      <phone>503-571-6181</phone>
    </contact>
    <investigator>
      <last_name>Richard Mularski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn State Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MaryCatherine Hess</last_name>
      <phone>717-531-6010</phone>
    </contact>
    <contact_backup>
      <last_name>Terry Novchich</last_name>
      <phone>(717) 531-1389</phone>
    </contact_backup>
    <investigator>
      <last_name>Michael Reed, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helga Criner</last_name>
      <phone>215-707-1559</phone>
      <email>lii-yoong.criner@tuhs.temple.edu</email>
    </contact>
    <investigator>
      <last_name>Gerard Criner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Ledezma, PhD</last_name>
      <phone>412-864-3368</phone>
      <email>ledezmacm@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Frank Sciurba, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Tennessee Medical Center</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37920</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Crystal Tinch</last_name>
      <phone>865-305-9100</phone>
      <phone_ext>290</phone_ext>
      <email>ctinch@noccr.com</email>
    </contact>
    <contact_backup>
      <last_name>Heather Hill</last_name>
      <phone>865-305-9100</phone>
      <phone_ext>279</phone_ext>
      <email>hhill@noccr.com</email>
    </contact_backup>
    <investigator>
      <last_name>Paul Branca, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheri Stewart</last_name>
      <phone>615-343-8010</phone>
      <email>cheri.stewart@vanderbilt.edu</email>
    </contact>
    <investigator>
      <last_name>Otis Rickman, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Southwestern Medical Center at Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megha Sharma</last_name>
      <phone>214-645-9730</phone>
      <email>megha.sharma@stsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Muhanned Abu-Hijleh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Michael DeBakey VA Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Perusich</last_name>
      <phone>713-794-7294</phone>
    </contact>
    <investigator>
      <last_name>Roberto Casal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique Ferranti</last_name>
      <phone>801-581-5811</phone>
      <email>dominique.ferranti@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Chak Reddy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fletcher Allen Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Ardren</last_name>
      <phone>802-656-7953</phone>
      <email>sara.ardren@vtmednet.org</email>
    </contact>
    <investigator>
      <last_name>Matt Kinsey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Frayser</last_name>
      <phone>804-828-7966</phone>
    </contact>
    <investigator>
      <last_name>Ray Shepherd, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barb Alivo</last_name>
      <phone>414-955-6994</phone>
    </contact>
    <investigator>
      <last_name>David Johnstone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Calgary</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4Z6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Curtis Dumonceaux</last_name>
      <email>cjdumonc@ucalgary.ca</email>
    </contact>
    <investigator>
      <last_name>Christopher Hergott, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y4E9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosalie Labelle</last_name>
      <phone>(613) 737-8899</phone>
      <phone_ext>72772</phone_ext>
      <email>rolabelle@toh.on.ca</email>
    </contact>
    <investigator>
      <last_name>Kayvan Amjadi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Laval University</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V 0A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josee Picard</last_name>
      <phone>(418) 656-8711 x2934</phone>
      <email>josee.picard@criucpq.ulaval.ca</email>
    </contact>
    <investigator>
      <last_name>Antoine Delage, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>January 16, 2017</lastchanged_date>
  <firstreceived_date>March 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endobronchial Valves</keyword>
  <keyword>Intrabronchial Valves</keyword>
  <keyword>Bronchial Valve</keyword>
  <keyword>Chronic Obstructive Pulmonary Disease</keyword>
  <keyword>COPD</keyword>
  <keyword>Pulmonary Disease, Chronic Obstructive</keyword>
  <keyword>Bronchoscopic Lung Volume Reduction</keyword>
  <keyword>BLVR</keyword>
  <keyword>TLVR</keyword>
  <keyword>Emphysema</keyword>
  <keyword>Pulmonary Emphysema</keyword>
  <keyword>Pathologic Process</keyword>
  <keyword>Lung Diseases</keyword>
  <keyword>Respiratory Tract Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Emphysema</mesh_term>
    <mesh_term>Pulmonary Emphysema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
